93306-78-6

Basic information

• Product Name: Acetic acid, [3-(hydroxymethyl)phenoxy]-, ethyl ester
• CAS NO: 93306-78-6
• Molecular Formula: C11H14O4
• Molecular Weight: 210.23
• Mol File: 93306-78-6.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Acetic acid, [3-(hydroxymethyl)phenoxy]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [3-(hydroxymethyl)phenoxy]-, ethyl ester(93306-78-6)
• EPA Substance Registry System: Acetic acid, [3-(hydroxymethyl)phenoxy]-, ethyl ester(93306-78-6)

Safety Data

• Hazardous Substances Data: 93306-78-6(Hazardous Substances Data)

Upstream product

• 7664-93-9 sulfuric acid 
• 6625-88-3 3-(hydroxymethyl)phenoxyacetic acid 
• 620-24-6 3-Hydroxybenzyl alcohol 
• 105-36-2 ethyl bromoacetate 
• 51264-68-7 ethyl 2-(3-formylphenoxy)acetate 

Downstream Products

• 6625-88-3 3-(hydroxymethyl)phenoxyacetic acid 
• 65706-41-4 ethyl 2-(3-(chloromethyl)phenoxy)acetate 
• 643091-11-6 ethyl [3-[[4-[2-[(tert-butoxycarbonyl)[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]phenoxy]methyl]-phenoxy]acetate 
• 204067-72-1 {3-[2-allyl-2-(thiophen-3-ylmethoxy)-pent-4-enyloxy]-benzyloxy}-tert-butyl-dimethyl-silane 
• 204067-71-0 tert-butyl-{3-[2-ethyl-2-(thiophen-3-ylmethoxy)-butoxy]-benzyloxy}-dimethyl-silane 
• 204067-76-5 {3-[2-allyl-2-(thiophen-3-ylmethoxy)-pent-4-enyloxy]-phenyl}-methanol 
• 204067-78-7 methanesulfonic acid 3-[2-ethyl-2-(thiophen-3-ylmethoxy)-butoxy]-benzyl ester 
• 204067-68-5 3-[3-(tert-butyl-dimethyl-silanyloxymethyl)-phenoxymethyl]-pentan-3-ol 
• 204067-79-8 methanesulfonic acid 3-[2-methyl-2-(thiophen-3-ylmethoxy)-propoxy]-benzyl ester 
• 204067-75-4 {3-[2-ethyl-2-(thiophen-3-ylmethoxy)-butoxy]-phenyl}-methanol 
• 204067-67-4 1-[3-(tert-butyl-dimethyl-silanyloxymethyl)-phenoxy]-2-methyl-propan-2-ol 
• 204067-74-3 {3-[2-methyl-2-(thiophen-3-ylmethoxy)-propoxy]-phenyl}-methanol 
• 204067-66-3 [3-(tert-butyl-dimethyl-silanyloxymethyl)-phenoxy]-acetic acid ethyl ester 

Relevant articles and documents

Compounds and Their Use in Treating Cancer

The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts and prodrugs thereof, where R1, R4, R5, R6, R7, Linker, X, Y, A, G, D and E have any of the meanings defined herein. This specification also relates to the use of such compounds and pharmaceutically acceptable salts and prodrugs thereof in methods of treatment of the human or animal body, for example in prevention or treatment of cancer. This specification also relates to processes and intermediate compounds involved in the preparation of such compounds and to pharmaceutical compositions containing them.

Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

-

Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738

The synthesis and biological properties of a novel squalene epoxidase inhibitor, FR194738, are described. This compound displayed potent in vitro inhibitory activities against squalene epoxidase and cholesterol synthesis, and lowered plasma cholesterol and triglyceride levels in dogs.